WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

Jane Sykes, BVSc, PhD, MPH, MBA, FNAP, summarizes the practical parts of the 2023 ACVIM consensus update on leptospirosis and explains what it means for general practice. She covers the biggest shift ...

Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one ...

A research team led by Senior Researcher Chanyong Park, Principal Researcher Dongkyu Lee, and Postdoctoral Researcher Changha ...

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...

Hepatitis C is a tiny virus with a significant impact. It's a small RNA virus that spreads through the blood and infects the liver. Even though today's medicines can cure it, hepatitis C remains a ...

A rapid heart attack test could significantly accelerate diagnosis and treatment for patients, experts have revealed, promising to cut waiting times in emergency departments. Suspected heart attacks ...

I maintain my buy rating on iShares Expanded Tech Sector ETF, expecting strong returns as tech stocks benefit from robust earnings, AI demand, and favorable macro conditions. IGM’s diversified ...

PHOENIX (AZFamily) — Thousands of people are diagnosed with valley fever every year in Arizona, and sometimes you can be misdiagnosed because the symptoms are so similar to other illnesses like the ...

Objectives To validate a rapid serological test (RST) for SARS-CoV-2 antibodies used in seroprevalence studies in healthcare providers, including primary healthcare providers (PHCPs) in Belgium.